Front Row Advisors’s Novavax NVAX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-200
| Closed | -$1K | – | 927 |
|
|
2023
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 882 |
|
|
2022
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 794 |
|
|
2022
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 711 |
|
|
2022
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 518 |
|
|
2022
Q1 | $15K | Hold |
200
| – | – | 0.01% | 470 |
|
|
2021
Q4 | $29K | Hold |
200
| – | – | 0.01% | 348 |
|
|
2021
Q3 | $41K | Hold |
200
| – | – | 0.02% | 290 |
|
|
2021
Q2 | $43K | Hold |
200
| – | – | 0.02% | 283 |
|
|
2021
Q1 | $36K | Hold |
200
| – | – | 0.02% | 297 |
|
|
2020
Q4 | $22K | Hold |
200
| – | – | 0.01% | 369 |
|
|
2020
Q3 | $25K | Buy |
+200
| New | +$25K | 0.01% | 344 |
|